Dedicated to building a team that advocates for patients; advocates for raising the bar of expectations; advocates for hope for patients with rare disease. As an executive for Retrophin, a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases for which there are currently no viable options for patients. Over 25 years of experience in life sciences sales and marketing. Leader or member of 16 teams that have launched 7 pharmaceuticals and 9 diagnostics. Therapeutic experience in urology, nephrology, gastroenterology, hepatology, psychiatry, neurology, pain management, and oncology.